Delivery Order SPE2DB24D2205-SPE2DB25FEFFX
- Not listed
- The Defense Logistics Agency awarded a $152,714.53 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $262,572.45 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products. The contract, with a completion date of July 23, 2025, represents a competitive, non-set-aside award utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $157,016.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine product, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,195.46 delivery order to AmerisourceBergen Drug Corp for one vial of Menveo (meningococcal conjugate vaccine A-C-Y-W-135) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $45K on July 23, 2025, for the supply of Menveo vaccine (5-dose vials). This competitively awarded, firm fixed-price delivery order is expected to be completed by July 24, 2025, and will be performed at the contractor's Conshohocken facility. The award was funded by the Defense Logistics Agency's Medical Supply Chain, which procures...
- The Defense Logistics Agency awarded a $169,665.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,739.98 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (A-C-Y-W-135-diphtheria) 0.5 mL vaccine product. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Menveo vaccine in a 10-dose vial configuration. This firm fixed-price delivery order, valued at $31,234.74, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award, which carries no set-aside designation, reflects a competitively awarded...
- The Defense Logistics Agency awarded a $15,760.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo (meningococcal vaccine) in a single-vial formulation (A-C-Y-W-135-DIP, 0.5mL). This non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through established federal...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFFXDelivery Order
The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, has demonstrated substantial capability in fulfilling federal medical procurement requirements through its extensive portfolio of Defense Logistics Agency contracts. The company supplies a broad spectrum of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Menveo vaccine delivery represents one of many competitively awarded transactions the company executes under its prime IDC with DLA, reinforcing its role as a critical vendor within the federal medical supply chain serving entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 7/23/25 |